Ed. Note: Sara Gorman will be joining us once a month to highlight different aspects of her forthcoming book on science denialism. Have you ever Read More
Dr. Samira Asma, Chief, Global NCD Program, CDC Over the past 18 years, I’ve worked with Ministries of Health and other partners in 180 countries to advance CDC’s overarching global health goals and accelerate strategies for the prevention and control of noncommunicable diseases (NCDs) and injuries. NCDs and injuries are responsible for millions of premature deaths, especially in low- and middle-income counties (LMICs). As public health practitioners, we have an important opportunity to work collaboratively to accelerate and scale up implementation of proven prevention and treatment strategies and measure their impact.
Ketamine is a valued anesthetic tool in all clinical practice settings. In LMICs, however, ketamine is indispensable for addressing the growing burden of surgical Read More
Lung cancer is the leading cause of cancer death in Australia.
Indigenous Australians have poorer cancer outcomes in terms of incidence mortality and survival compared with non-Indigenous Australians.
Associated Press: Study: Cancer drugs less affordable in poor nations than U.S. “Cancer drugs predictably cost much more in the U.S. than in poor countries and even other wealthy nations, but a study shows they are less affordable in some developing countries despite the lower price. Relative to their ability to pay, cancer patients in…More
PLOS Medicine’s Senior Research Editor Clare Garvey interviews Elaine Mardis and Marc Ladanyi, Guest Editors for our Special Issue on the Actionable Cancer Genome ; Elaine Mardis is co-Director of the McDonnell Genome Institute and Robert E. and
Humanosphere: In Haiti, breast cancer doesn’t need to be a death sentence Humanosphere journalist Lisa Nikolau discusses the challenges to addressing breast cancer in Haiti, citing fear, stigma, and a lack of support for patients. However, she notes progress, writing, “There’s no doubt that cancer care in Haiti has a long road to navigate before…More
Cancer kills more people in low- and middle-income countries than HIV/AIDS, tuberculosis and malaria combined. And for people in the developing world – where the survival rate of breast cancer is less than half that of high-income countries – breast cancer can seem like a death sentence. But it doesn’t need to be – not
Reuters: How Wellcome and Gates charities profit from helping biotech “The Wellcome Trust medical charity is to profit from U.S. approval of a new diagnostic cancer test, the first commercial product funded by the organization since the sale of its pharmaceuticals business to Glaxo in 1995. The regulatory green light shows how the world’s health…More
Anshu, a teenager who lives in a village in Raebareli District of Uttar Pradesh, India, was a friendly and lively girl. But when she reached puberty, she had very little information about how to manage her menstruation, and she began to lose her confidence. During those days each month she did not venture out from her […] ; ; ; ;Related StoriesHealthy markets: essential to improving health and saving livesThe profound effect of girls’ dreamsJosé Jerónimo: a cancer hero among us ;
Raquel Peck is the CEO of the World Hepatitis Alliance (WHA), she shares her hope that stronger action on viral hepatitis will be high on the agenda for the 69th World Health Assembly in Geneva (convening this week). Raquel’s piece is part of a series of articles Translational Global Health will run on WHA69. If you or your organisation have a particular focus at the Assembly you feel requires urgent attention, contact our Editor. We are at a turning point. This week, 194 countries will convene to decide the fate of millions of people living with viral hepatitis. At the 69th World Health Assembly in Geneva (23 – 28 May), governments will deliberate on the adoption of WHO’s first ever Global Health Sector Strategy for Viral Hepatitis (GHSS), which sets a goal of eliminating hepatitis B and C by 2030, two significant public health issues that can lead to cirrhosis, liver cancer and death.
As the global burden of disease shifts from infectious diseases to non-communicable diseases (NCDs), cancer has increasingly become a major contributor to morbidity and mortality in low-income and middle-income countries (LMICs). Major reasons for these shifts include increasing life expectancy and changing diets and lifestyles. An estimated 14·1 million new cases and 8·2 million cancer deaths occurred worldwide in 2012, with more than 65% of cancer deaths occurring in LMICs.1 In Nigeria, cervical cancer and breast cancer are two of the leading causes of cancer deaths in women, accounting for more than 40% of all women’s cancer and about two-thirds of cancer deaths.
Publication date: June 2016 Source:Social Science & Medicine, Volume 159 Author(s): Kayoll V.
Recently, PATH’s Dr. José Jerónimo received the highest award that the American Society for Colposcopy and Cervical Pathology (ASCCP) can bestow—the Distinguished Scientific Award for significant positive impact on underserved populations. ASCCP works on cervical health worldwide and recognized Jose for his contributions in low-resource settings. José will be presenting a talk on cervical cancer […] ; ; ; ;Related StoriesHealthy markets: essential to improving health and saving livesPolio, pride, and love: the story of an exceptional mother and her sonKeeping a promise to mothers and children ;